Apr 282020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, MA – Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced the appointment of Christopher J. Coughlin to its board of directors. Mr. ...

Karuna Therapeutics appoints Chris Coughlin to the Board of Directors and its Audit Committee

Karuna Therapeutics appoints Chris Coughlin to the Board of Directors and its Audit Committee

From:: Karuna Therapeutics appoints Chris Coughlin to the Board of Directors and its Audit Committee

Sorry, the comment form is closed at this time.